secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axe Compute Inc. (AGPU)
CIK:        0001446159
Form:       8-K
Filed at:   2023-03-21T23:59:59+00:00
Accession:  0001171843-23-001807
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Predictive Oncology FY2022: Net loss $25.7M, revenue $1.5M, impairments total $10.6M
--------------------------------------------------------------------------------

- Net loss of $25.7M on total revenue of $1.5M; diluted EPS -$0.35.
- Revenue $1.51M vs $1.42M prior year; gross margin stable at 66%.
- Recorded $7.23M goodwill impairment and $3.35M intangible impairment for zPREDICTA.
- Cash and equivalents $22.1M at year end, down from $28.2M in 2021.
- Operations expense up 41% to $3.8M; sales & marketing expense rose 75% to $1.36M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446159/000117184323001807/0001171843-23-001807-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446159/000117184323001807/f8k_032123.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-001807

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer